1-85034227-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018298.11(MCOLN3):c.421G>A(p.Val141Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000114 in 1,614,120 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018298.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCOLN3 | NM_018298.11 | c.421G>A | p.Val141Ile | missense_variant | 4/13 | ENST00000370589.7 | NP_060768.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MCOLN3 | ENST00000370589.7 | c.421G>A | p.Val141Ile | missense_variant | 4/13 | 1 | NM_018298.11 | ENSP00000359621 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000167 AC: 42AN: 251412Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135896
GnomAD4 exome AF: 0.0000951 AC: 139AN: 1461842Hom.: 1 Cov.: 31 AF XY: 0.000109 AC XY: 79AN XY: 727218
GnomAD4 genome AF: 0.000296 AC: 45AN: 152278Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2024 | The c.421G>A (p.V141I) alteration is located in exon 4 (coding exon 3) of the MCOLN3 gene. This alteration results from a G to A substitution at nucleotide position 421, causing the valine (V) at amino acid position 141 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at